CAMRESE Trademark

Trademark Overview

On Wednesday, May 12, 2010, a trademark application was filed for CAMRESE with the United States Patent and Trademark Office. The USPTO has given the CAMRESE trademark a serial number of 85036659. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 6, 2022. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The CAMRESE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, oral contraceptives, hormone replacement therapy preparations and pharmaceutical preparations, namely, hormonal agents for treating hormone disorders and conditions related to women's health
camrese

General Information

Serial Number85036659
Word MarkCAMRESE
Filing DateWednesday, May 12, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 6, 2022
Registration Number4046272
Registration DateTuesday, October 25, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2010

Trademark Statements

Goods and ServicesPharmaceuticals, namely, oral contraceptives, hormone replacement therapy preparations and pharmaceutical preparations, namely, hormonal agents for treating hormone disorders and conditions related to women's health

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateThursday, July 28, 2011
First Use In Commerce DateThursday, July 28, 2011

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Friday, May 6, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, October 25, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, October 17, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, October 17, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 17, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 25, 2017TEAS SECTION 8 & 15 RECEIVED
Monday, September 25, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 25, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 25, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, September 21, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 20, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, September 6, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 3, 2011STATEMENT OF USE PROCESSING COMPLETE
Monday, August 1, 2011USE AMENDMENT FILED
Monday, August 1, 2011TEAS STATEMENT OF USE RECEIVED
Friday, June 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2011SOU EXTENSION 1 GRANTED
Monday, June 13, 2011SOU EXTENSION 1 FILED
Wednesday, June 15, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 13, 2011TEAS EXTENSION RECEIVED
Tuesday, December 21, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 26, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2010PUBLISHED FOR OPPOSITION
Monday, September 20, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 20, 2010ASSIGNED TO LIE
Friday, September 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 3, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 2, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 2, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 25, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2010NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2010NON-FINAL ACTION WRITTEN
Tuesday, August 24, 2010ASSIGNED TO EXAMINER
Tuesday, May 18, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 15, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

camrese preparations hormone namely disorders treating conditions related women agents health